Conduct a patch test before fully integrating a new GHK-Cu product, such as serums, eye creams, or lotions
A federal advisory committee voted Thursday to recommend that compounding pharmacies be permitted to produce BPC-157, a peptide that has gained a devoted following in wellness communities even though it has never received formal FDA approval
Timeline depends on the compound and the outcome measured
Researchers have safely applied these doses for up to two weeks based on the available case reports [6, 8, 14]
In rat models, TB-500 has shown faster tendon healing, reduced muscle scarring, improved cardiac repair post-infarct, and better wound closure
Wolverine stack protocol for shoulder injuries Based on reported protocols in the literature: BPC-157 component: 250 to 500 mcg daily, split into morning and evening doses Subcutaneous injection, ideally near the shoulder (periarticular) with medical guidance, or abdomen/thigh for systemic delivery TB-500 component: 750 to 2000 mcg twice weekly during loading phase (first two to four weeks) 500 to 1000 mcg twice weekly during maintenance phase Subcutaneous injection at any standard site Combined cycle: Loading phase: four weeks Maintenance: four to eight additional weeks Total cycle: eight to twelve weeks Rest period: four to six weeks between cycles if needed For precise dosing calculations, the peptide calculator helps determine exact amounts based on your reconstitution volume and vial size
